Russian
French
 
 
-ISO 9001:2000
   
 

Mucogrip

The wet slippery mucosa of the oral cavity causes washing out of the conventional mouth ulcer formulations within a few minutes after application. As a result, patient does not get enough relief and healing of ulcer takes a prolonged time.

Tess is manufactured by innovative proprietary Mucogrip Technology that makes it possible for the drug to stay on the ulcer for a longer time as it sticks firmly on the wet, slippery and moving mucosa of the mouth. It forms a protective film over the mouth ulcer. It, therefore, ensures drug delivery and speedy healing of ulcers.

The Triamcinolone Acetonide present in Tess Buccal Paste has a 3 way action:

Anti-inflammatory: Inhibits release of PAF, Prostaglandin, Leukotrienes, etc.

Accelerates tissue repair: By a nonspecific action.

Forms a protective film: Protects the tissues from further damage.

 

back to Innovative Technologies

 
- - -
Overview
AquaTech
Decompaction
DrySolve
Duophase
IFC
Intraoral Drug Delivery
Lipisol
LipoTech
LiquiCaps
Matrix
Maxisorb
Microsolve
Mucogrip
Organogel
Parenteral Nano Emulsion
Pre Filled Syringes (PFS)
Quick Penetrating Solution (QPS)
SoluTech
 

Products manufactured using Mucogrip Technology:

Triamcinolone Acetonide 0.1% w/v Buccal Paste

Also visit:
http://www.tessbuccal.com

 
Tess
Tess
   

Home | Company | Products | Technologies | International Business | Media Coverage | Human Resources | Research Publications | Partnering

Copyright ę 2009 Troikaa Pharmaceuticals Ltd. - Disclaimer